HBsAg LEVELS AT THE END OF LONG-TERM THERAPY (EOT) WITH NUCLEOS(T)IDE ANALOGUES (NA) AFFECT THE OUTCOMES OF NON-CIRRHOTIC PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B (CHBE-)
HEPATOLOGY（2019）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined